Martin E. Wohlfahrt
- Molecular Biology
- Oncology top 5%
- Genetics top 5%
- Biomedical Engineering top 10%
- Immunology top 10%
- Co-authors
- Weihang JiSmitha P.S. PillaiMatthias T. StephanLaura E. McKnightHowell MoffettSirkka B. StephanHans‐Peter KiemJennifer E. Adair
- Topics
- Virus-based gene therapy research (9 papers)CRISPR and Genetic Engineering (5 papers)CAR-T cell therapy research (5 papers)
- Cited by
- OncologyImmunologyGenetics
- Partner nations
- United StatesGermanyAustria
In The Last Decade
Martin E. Wohlfahrt
16 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 87
- Molecular Biology 593
- Oncology 575
- Genetics 350
- Biomedical Engineering 329
- Immunology 323
Countries citing papers authored by Martin E. Wohlfahrt
This map shows the geographic impact of Martin E. Wohlfahrt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin E. Wohlfahrt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin E. Wohlfahrt more than expected).
Fields of papers citing papers by Martin E. Wohlfahrt
This network shows the impact of papers produced by Martin E. Wohlfahrt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin E. Wohlfahrt. The network helps show where Martin E. Wohlfahrt may publish in the future.
Co-authorship network of co-authors of Martin E. Wohlfahrt
This figure shows the co-authorship network connecting the top 25 collaborators of Martin E. Wohlfahrt. A scholar is included among the top collaborators of Martin E. Wohlfahrt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin E. Wohlfahrt. Martin E. Wohlfahrt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 177 | |
| 2 | 6 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriersbreakdown → | 593 |
| 6 | 28 | |
| 7 | 34 | |
| 8 | 5 | |
| 9 | 43 | |
| 10 | 23 | |
| 11 | 54 | |
| 12 | 9 | |
| 13 | 13 | |
| 14 | 57 | |
| 15 | 55 | |
| 16 | 2 |
About Martin E. Wohlfahrt
Martin E. Wohlfahrt is a scholar working on Genetics, Virology and Immunology, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), CRISPR and Genetic Engineering (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (575 citations), Immunology (323 citations) and Genetics (350 citations). Martin E. Wohlfahrt has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Weihang Ji, Smitha P.S. Pillai, Matthias T. Stephan, Laura E. McKnight, Howell Moffett, Sirkka B. Stephan, Hans‐Peter Kiem, Jennifer E. Adair, Brian C. Beard and Keith Andrews. Their work appears in journals such as Nature Communications, Blood and Nature Nanotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.